HUMULIN-N (ISOPHANE) 100 Units/ml Price

Overview

Welcome to Dwaey, specifically on HUMULIN-N (ISOPHANE) 100 Units/ml Injection page.
This medicine contains an important and useful components, as it consists of Insulin - Isophane (human).
HUMULIN-N (ISOPHANE) 100 Units/ml is available in the market in concentration 100 U/ml and in the form of Injection.

ELI LILLY & CO INC. is the producer of HUMULIN-N (ISOPHANE) 100 Units/ml and it is imported from USA, The most popular alternatives of HUMULIN-N (ISOPHANE) 100 Units/ml are listed downward .

Mode Of Action

Insulin lowers blood glucose levels. It regulates carbohydrate, protein and fat metabolism by inhibiting hepatic glucose production and lipolysis, and enhancing peripheral glucose disposal. The various insulin formulations are classified according to their durations of action after SC Inj. They are divided into short-, intermediate-, or long-acting insulin. Soluble insulin (also known as 'neutral insulin' or 'regular insulin') is a short-acting preparation. To extend the duration of action of insulin, preparations are formulated as suspensions in 2 methods. The 1st method involves complexing insulin with a protein so that it is slowly released, e.g. protamine zinc insulin (contains an excess of protamine) and isophane insulin (or NPH insulin which contains equal amounts of protamine and insulin). An alternative method is particle size modification e.g. insulin zinc suspensions. While all the formulations can be admin by SC inj, most by IM inj, only soluble insulin can be admin by IV. Compared to SC inj, IM admin usually has a faster onset of action, with a shorter duration of action.

Indication

• Diabetes mellitus

Precaution

Pregnancy (insulin requirements tend to fall during the 1st trimester, increase during the 2nd and 3rd) and lactation. Caution with decreased insulin requirements: Diarrhea, nausea/vomiting, malabsorption, hypothyroidism, renal impairment, hepatic impairment Hypokalemia may occur Not for IV or IM administration Use with caution in renal and hepatic impairment (dosage requirements may be reduced) Caution with increased insulin requirements: Fever, hyperthyroidism, trauma, infection, surgery Lactation: Safe to use while breastfeeding

Side Effects

• Allergic reactions. Injection site reaction
• lipodystrophy
• pruritus
• rash
• lipoatrophy
• hypokalaemia
• blurred vision. Hypoglycaemia
• insulin resistance. Headache
• Influenza-like symptoms
• Dyspepsia
• Diarrhea
• Back pain
• Pharyngitis

Contra indication

Hypoglycaemia.Hypersensitivity to any of the components.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.